6 ms·
Vox did a piece on this[1]. Basically, if you're young, the risk of death is about equal to a kidney donation, which is a procedure we allow. Participating in
by Wowfunhappy 7y ago
Vox did a piece on this[1]. Basically, if you're young, the risk of death is about equal to a kidney donation, which is a procedure we allow.
Participating in a trial like this could save many more lives than donating a kidney. And, if you live in e.g. NYC, there's a decent chance you're going to get COVID anyway, trial or no.
Separately from that... y'know, there are currently lots of health care workers taking care of COVID patients—frequently without proper PPE—and getting sick from it. If we as a society have agreed this is worth the risk, why not a challenge trial to develop a vaccine?
I'm honestly a little surprised there's even a debate about this. The choice seems pretty clear to me.
---
[1] https://www.vox.com/future-perfect/2020/4/9/21209593/coronavirus-vaccine-human-trials-explained https://www.vox.com/future-perfect/2020/4/9/21209593/coronav...
- refurb 7y agoI'm not disagreeing with your logic. The risk would be reasonably low if the subjects are young and healthy. However, you can still get similar information by just dropping the control arm in this trial. Give a bunch of people the vaccine and exposed them to the virus. Sure it's not as good as having an untreated control arm, but you're also reducing the risk of someone in the control group dying.
- Wowfunhappy 7y agoThe data is of very little use without a control. You could compare it to overall Coronavirus death rates, but those numbers are biased in all sorts of ways (for instance, fully asymptomatic cases).
- refurb 7y agoI would disagree with "very little use". Uncontrolled trials are done all the time. You basically collect "nature history" data and compare it to that. In addition, the mechanism of vaccines is very well know. You can vaccinate and measure antibody formation. You could still develop a vaccine without a control and have confidence that it works.
- astura 7y agoPretty sure uncontrolled trials are common at the latest stages of drug development. It's called a single-arm trial. Source: I once participated in a phase III open-label single-arm trial.
- s1artibartfast 7y agoThey exist, but are usually not sufficient to support a drug or vaccine approval. The standard is two well controlled studies, but additional open label trials may be used to address specific health authority concerns. If you are interested, you can look up the other trials the drug may have gone through.
- kerkeslager 7y ago> Vox did a piece on this. Basically, if you're young, the risk of death is about equal to a kidney donation, which is a procedure we allow. I haven't seen the Vox article, but if that's what they said, it's total bullshit and irresponsible journalism, and I'd request that you do your part by not repeating that. The first kidney donation was in 1954. We have 66 years worth of data--plenty of time for many kidney donors to live out their lives and have the problems caused by kidney donation, so we have a pretty good idea of what the long-term effects of kidney donation are. We don't know what the long-term effects of coronavirus are because nobody has had it and then lived long term. The first case we know of was in November 2019--five months ago. Vox can't say that "if you're young, the risk of death is about equal to a kidney donation", because we do not know what the risks are. If scientists infected a bunch of 20 year olds with Covid in 2020 and by 2050, 40% of them die of lung cancer before the age of 50, is that something you'd be cool with? Because that might be reality--it's impossible to know. To be clear, I'm not saying Covid-19 causes lung cancer. I'm saying we cannot possibly know ANYTHING about the long term effect of Covid-19. We shouldn't assume that it causes lung cancer, but we also shouldn't assume it's no more dangerous than a kidney donation. We shouldn't assume, period. So statements like, "if you're young, the risk of death is about equal to a kidney donation" are lies. And I would implore you to not spread that misinformation because it potentially has deadly consequences.
- eveningcoffee 7y agoGood points. Only obvious solution is to give to the health care workers and you have your control group.
- Wowfunhappy 7y agoI take your point, but calling the comparison "lies" based on the possibility of long-term implications we know nothing about seems like a big stretch to me. We don't know the long-term effects of 5G either. > If scientists infected a bunch of 20 year olds with Covid in 2020 and by 2050, 40% of them die of lung cancer before the age of 50, is that something you'd be cool with? If it saves the lives of a bunch of nurses in the process? I don't know—I think I'm cool with a possibility of it, yes. Especially when those same people could also catch the virus naturally. Also, I edited my original post to add a link to the Vox article. It's quite a bit longer / more expansive, and worth a read.
- blackrock 7y agoBut if you donate a kidney, then you’ll now have a pre-existing condition. Which means you’ll be denied access to health insurance.
- new299 7y agoYou, and the vox article, seem to assume that the risks are all associated with COVID19 in the trial as similar to those normally associated with COVID19 in the human population.. One of the issues with vaccine development is that vaccines can result in worse infections [1]. If the issue was just “this might not work, but it won’t cause any harm”. You would obviously give this to healthcare workers immediately. But that does not appear to be the case. [1] https://www.pnas.org/content/117/15/8218 https://www.pnas.org/content/117/15/8218
- Wowfunhappy 7y agoWell, I assume the challenge trial would be done to test efficacy after you've tested safety. Is this aspect substantially different than with any other vaccine trial?
- mdorazio 7y agoThe difference is right now healthcare facilities and providers are overloaded, so if there are adverse effects of a trial that require treatment, people could end up dead. Normally you would have hospitals ready to handle such cases, but there's zero guarantee of that today.
- SpicyLemonZest 7y agoI'm sure we can all agree that trials with the potential to require medical intervention shouldn't take place in areas with overloaded hospitals. But most areas of most countries don't have overloaded hospitals right now.
- new299 7y agoAll phases will be testing for safety to varying degrees. So... a challenge trial at phase III will still have risks. Right now, I don’t think we have any vaccines ready to enter phase III? COVID19 does seem to be actively spreading in the population currently. So I don’t think there would be an issue finding participants for a phase III trial. At the point that we’re ready for phase III trials. If there is no population where COVID19 is actively spreading, perhaps challenge trials could be considered?